[ Thu, May 13th 2021 ]: WOPRAI
[ Thu, May 13th 2021 ]: WOPRAI
[ Thu, May 13th 2021 ]: WOPRAI
[ Thu, May 13th 2021 ]: WOPRAI
[ Wed, May 12th 2021 ]: WOPRAI
[ Wed, May 12th 2021 ]: WOPRAI
[ Wed, May 12th 2021 ]: WOPRAI
[ Wed, May 12th 2021 ]: WOPRAI
[ Wed, May 12th 2021 ]: WOPRAI
[ Wed, May 12th 2021 ]: WOPRAI
[ Wed, May 12th 2021 ]: WOPRAI
[ Wed, May 12th 2021 ]: WOPRAI
[ Wed, May 12th 2021 ]: WOPRAI
[ Wed, May 12th 2021 ]: WOPRAI
[ Wed, May 12th 2021 ]: WOPRAI
[ Wed, May 12th 2021 ]: WOPRAI
[ Wed, May 12th 2021 ]: WOPRAI
[ Wed, May 12th 2021 ]: WOPRAI
[ Wed, May 12th 2021 ]: WOPRAI
[ Wed, May 12th 2021 ]: WOPRAI
[ Wed, May 12th 2021 ]: WOPRAI
[ Wed, May 12th 2021 ]: WOPRAI
[ Wed, May 12th 2021 ]: WOPRAI
[ Wed, May 12th 2021 ]: WOPRAI
[ Wed, May 12th 2021 ]: WOPRAI
[ Wed, May 12th 2021 ]: WOPRAI
[ Wed, May 12th 2021 ]: WOPRAI
[ Wed, May 12th 2021 ]: WOPRAI
[ Wed, May 12th 2021 ]: WOPRAI
[ Wed, May 12th 2021 ]: WOPRAI
[ Wed, May 12th 2021 ]: WOPRAI
[ Wed, May 12th 2021 ]: WOPRAI
[ Wed, May 12th 2021 ]: WOPRAI
[ Wed, May 12th 2021 ]: WOPRAI
[ Wed, May 12th 2021 ]: WOPRAI
[ Wed, May 12th 2021 ]: WOPRAI
[ Wed, May 12th 2021 ]: WOPRAI
[ Wed, May 12th 2021 ]: WOPRAI
[ Wed, May 12th 2021 ]: WOPRAI
[ Wed, May 12th 2021 ]: WOPRAI
[ Wed, May 12th 2021 ]: WOPRAI
[ Wed, May 12th 2021 ]: WOPRAI
[ Wed, May 12th 2021 ]: WOPRAI
[ Wed, May 12th 2021 ]: WOPRAI
[ Tue, May 11th 2021 ]: WOPRAI
[ Tue, May 11th 2021 ]: WOPRAI
[ Tue, May 11th 2021 ]: WOPRAI
[ Tue, May 11th 2021 ]: WOPRAI
Tejas Savant Maintained (BDSX) at Buy with Decreased Target to $23 on, May 12th, 2021
- 🞛 This publication is a summary or evaluation of another publication
Tejas Savant of Morgan Stanley, Maintained "Biodesix, Inc." (BDSX) at Buy with Decreased Target from $25 to $23 on, May 12th, 2021.
Tejas has made no other calls on BDSX in the last 4 months.
There is 1 other peer that has a rating on BDSX. Out of the 1 peers that are also analyzing BDSX, 0 agree with Tejas's Rating of Hold.
This is the rating of the analyst that currently disagrees with Tejas
- Max Masucci of "Canaccord Genuity" Maintained at Strong Buy with Increased Target to $31 on, Tuesday, February 2nd, 2021